{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T00:35:38Z","timestamp":1792802138153,"version":"4.5.0"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,8,12]],"date-time":"2020-08-12T00:00:00Z","timestamp":1597190400000},"content-version":"vor","delay-in-days":11,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Tuberculosis and Other Mycobacterial Diseases"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1016\/j.jctube.2020.100180","type":"journal-article","created":{"date-parts":[[2020,8,13]],"date-time":"2020-08-13T02:43:47Z","timestamp":1597286627000},"page":"100180","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Tuberculosis preventive therapy (TPT) to prevent tuberculosis co-infection among adults with HIV-associated cryptococcal meningitis: A clinician\u2019s perspective"],"prefix":"10.1016","volume":"20","author":[{"given":"John","family":"Kasibante","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morris K.","family":"Rutakingirwa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enock","family":"Kagimu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth","family":"Ssebambulidde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jayne","family":"Ellis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lillian","family":"Tugume","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward","family":"Mpoza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fiona","family":"Cresswell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David B.","family":"Meya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jctube.2020.100180_b0005","unstructured":"World Health Organisation, G., Switzerland., Global tuberculosis report 2019. https:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/329368\/9789241565714-eng.pdf?ua=1, 2019. (Licence: CC BY-NC-SA 3.0 IGO.) [accessed 28th July 2020]."},{"issue":"8","key":"10.1016\/j.jctube.2020.100180_b0010","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/S1473-3099(17)30243-8","article-title":"Global burden of disease of HIV-associated cryptococcal meningitis: an updated analysis","volume":"17","author":"Rajasingham","year":"2017","journal-title":"Lancet Infect Dis."},{"key":"10.1016\/j.jctube.2020.100180_b0015","article-title":"Tuberculosis in HIV-Associated Cryptococcal Meningitis is Associated with an Increased Risk of Death","author":"Rutakingirwa","year":"202093781","journal-title":"J Clin Med."},{"key":"10.1016\/j.jctube.2020.100180_b0020","doi-asserted-by":"crossref","unstructured":"Cresswell FV, Ellis J, Kagimu E, et al. Standardized Urine-Based Tuberculosis (TB) Screening With TB-Lipoarabinomannan and Xpert MTB\/RIF Ultra in Ugandan Adults With Advanced Human Immunodeficiency Virus Disease and Suspected Meningitis.Open Forum Infect Dis. 2020;7(4):ofaa100. Published 2020 Mar 24. doi:10.1093\/ofid\/ofaa100.","DOI":"10.1093\/ofid\/ofaa100"},{"key":"10.1016\/j.jctube.2020.100180_b0025","unstructured":"WHO, World Health Organisation Global Tuberculosis Report, Executive summary 2019. https:\/\/www.who.int\/tb\/publications\/global_report\/GraphicExecutiveSummary.pdf?ua=1 [accessed 28th July 2020]."},{"issue":"11","key":"10.1016\/j.jctube.2020.100180_b0030","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1056\/NEJMoa1806808","article-title":"One Month of Rifapentine plus Isoniazid to Prevent HIV-Related Tuberculosis","volume":"380","author":"Swindells","year":"2019","journal-title":"N Engl J Med."},{"issue":"Suppl 5","key":"10.1016\/j.jctube.2020.100180_b0035","doi-asserted-by":"crossref","first-page":"S29","DOI":"10.1097\/01.aids.0000391019.10661.66","article-title":"Adverse events with isoniazid preventive therapy: experience from a large trial","volume":"24","author":"Grant","year":"2010","journal-title":"AIDS."},{"key":"10.1016\/j.jctube.2020.100180_b0040","doi-asserted-by":"crossref","unstructured":"TEMPRANO ANRS 12136 Study Group, Danel C, Moh R, et al. A Trial of Early Antiretrovirals and Isoniazid Preventive Therapy in Africa.N Engl J Med. 2015;373(9):808-822. doi:10.1056\/NEJMoa1507198.","DOI":"10.1056\/NEJMoa1507198"},{"issue":"4","key":"10.1016\/j.jctube.2020.100180_b0045","doi-asserted-by":"crossref","first-page":"248","DOI":"10.7326\/M17-0609","article-title":"Treatment of Latent Tuberculosis Infection: An Updated Network Meta-analysis","volume":"167","author":"Zenner","year":"2017","journal-title":"Ann Intern Med."},{"key":"10.1016\/j.jctube.2020.100180_b0050","unstructured":"WHO, WHO operational handbook on tuberculosis. Module 1: prevention - tuberculosis preventive treatment. Geneva: World Health Organization; 2020. Licence: CC BY-NC-SA 3.0 IGO. https:\/\/apps.who.int\/iris\/rest\/bitstreams\/1272664\/retrieve.[accessed 28th July 2020]."},{"key":"10.1016\/j.jctube.2020.100180_b0055","unstructured":"WHO and G. World Health Organisation, Switzerland., Country profiles for 30 high tb burden countries. https:\/\/www.who.int\/tb\/publications\/global_report\/tb19_report_country_profiles_15october2019.pdf?ua=1 [accessed 28 July 2020]."},{"issue":"26","key":"10.1016\/j.jctube.2020.100180_b0060","doi-asserted-by":"crossref","first-page":"2487","DOI":"10.1056\/NEJMoa1312884","article-title":"Timing of antiretroviral therapy after diagnosis of cryptococcal meningitis","volume":"370","author":"Boulware","year":"2014","journal-title":"N Engl J Med."},{"key":"10.1016\/j.jctube.2020.100180_b0065","doi-asserted-by":"crossref","unstructured":"Kaplan R, Hermans S, Caldwell J, Jennings K, Bekker LG, Wood R. HIV and TB co-infection in the ART era: CD4 count distributions and TB case fatality in Cape Town.BMC Infect Dis. 2018;18(1):356. Published 2018 Jul 31. doi:10.1186\/s12879-018-3256-9.","DOI":"10.1186\/s12879-018-3256-9"},{"issue":"914","key":"10.1016\/j.jctube.2020.100180_b0070","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1136\/pgmj.77.914.769","article-title":"Clinical presentation, natural history, and cumulative death rates of 230 adults with primary cryptococcal meningitis in Zambian AIDS patients treated under local conditions","volume":"77","author":"Mwaba","year":"2001","journal-title":"Postgrad Med J."},{"issue":"2","key":"10.1016\/j.jctube.2020.100180_b0075","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1378\/chest.129.2.333","article-title":"Pulmonary cryptococcosis: comparison of clinical and radiographic characteristics in immunocompetent and immunocompromised patients","volume":"129","author":"Chang","year":"2006","journal-title":"Chest"},{"key":"10.1016\/j.jctube.2020.100180_b0080","article-title":"Abdominal Lymphonodular Cryptococcosis in an Immunocompetent Child","volume":"2015","author":"Zaidi","year":"2015","journal-title":"Case Rep Pediatr."},{"issue":"15","key":"10.1016\/j.jctube.2020.100180_b0085","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1097\/QAD.0000000000000802","article-title":"Prevalence of tuberculosis in post-mortem studies of HIV-infected adults and children in resource-limited settings: a systematic review and meta-analysis","volume":"29","author":"Gupta","year":"2015","journal-title":"AIDS."},{"key":"10.1016\/j.jctube.2020.100180_b0090","doi-asserted-by":"crossref","unstructured":"A Andama A, Jaganath D, Crowder R, et al. Accuracy and incremental yield of urine Xpert MTB\/RIF Ultra versus Determine TB-LAM for diagnosis of pulmonary tuberculosis.Diagn Microbiol Infect Dis. 2020;96(1):114892. doi:10.1016\/j.diagmicrobio.2019.114892.","DOI":"10.1016\/j.diagmicrobio.2019.114892"},{"key":"10.1016\/j.jctube.2020.100180_b0095","doi-asserted-by":"crossref","unstructured":"Kohli M, Schiller I, Dendukuri N, et al. Xpert\u00aeMTB\/RIF assay for extrapulmonary tuberculosis and rifampicin resistance.Cochrane Database Syst Rev. 2018;8(8):CD012768. Published 2018 Aug 27. doi:10.1002\/14651858.CD012768.pub2.","DOI":"10.1002\/14651858.CD012768.pub2"},{"issue":"6","key":"10.1016\/j.jctube.2020.100180_b0100","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1183\/09031936.00025711","article-title":"Diagnosing tuberculosis with urine lipoarabinomannan: systematic review and meta-analysis","volume":"38","author":"Minion","year":"2011","journal-title":"Eur Respir J."},{"issue":"6","key":"10.1016\/j.jctube.2020.100180_b0105","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1111\/bcp.12885","article-title":"Mechanism of isoniazid-induced hepatotoxicity: then and now","volume":"81","author":"Metushi","year":"2016","journal-title":"Br J Clin Pharmacol."},{"issue":"5","key":"10.1016\/j.jctube.2020.100180_b0110","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1001\/archinte.1991.00400050150032","article-title":"Fluconazole-related hepatotoxicity in patients with acquired immunodeficiency syndrome","volume":"151","author":"Mu\u0144oz","year":"1991","journal-title":"Arch Intern Med."},{"key":"10.1016\/j.jctube.2020.100180_b0115","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1159\/000194958","article-title":"Pharmacological study of rifampicin after repeated high dosage during intermittent combined therapy. II. Bilirubin levels and other biochemical determinations","volume":"28","author":"Verbist","year":"1971","journal-title":"Respiration."},{"issue":"1","key":"10.1016\/j.jctube.2020.100180_b0120","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1097\/QAI.0000000000001641","article-title":"Hepatotoxicity During Isoniazid Preventive Therapy and Antiretroviral Therapy in People Living With HIV With Severe Immunosuppression: A Secondary Analysis of a Multi-Country Open-Label Randomized Controlled Clinical Trial","volume":"78","author":"Ngongondo","year":"2018","journal-title":"J Acquir Immune Defic Syndr."},{"issue":"2","key":"10.1016\/j.jctube.2020.100180_b0125","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1164\/rccm.200911-1783OC","article-title":"Isoniazid-associated hepatitis and antiretroviral drugs during tuberculosis prophylaxis in hiv-infected adults in Botswana","volume":"182","author":"Tedla","year":"2010","journal-title":"Am J Respir Crit Care Med."},{"issue":"2","key":"10.1016\/j.jctube.2020.100180_b0130","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1093\/cid\/ciy082","article-title":"Cytokine-Mediated Systemic Adverse Drug Reactions in a Drug-Drug Interaction Study of Dolutegravir With Once-Weekly Isoniazid and Rifapentine","volume":"67","author":"Brooks","year":"2018","journal-title":"Clin Infect Dis."},{"key":"10.1016\/j.jctube.2020.100180_b0135","unstructured":"Dooley KE, Churchyard G, Radojka M. Savic RM, et al., safety & pk of weekly rifapentine\/isoniazid (3hp) in adults with hiv on dolutegravir. Conference on Retrovirals and Opportunitic Infections (CROI), 2020."},{"key":"10.1016\/j.jctube.2020.100180_b0140","doi-asserted-by":"crossref","unstructured":"Tenforde MW, Shapiro AE, Rouse B, et al. Treatment for HIV-associated cryptococcal meningitis.Cochrane Database Syst Rev. 2018;7(7):CD005647. Published 2018 Jul 25. doi:10.1002\/14651858.CD005647.pub3.","DOI":"10.1002\/14651858.CD005647.pub3"},{"key":"10.1016\/j.jctube.2020.100180_b0145","doi-asserted-by":"crossref","unstructured":"Balcells, M.E., et al., Isoniazid preventive therapy and risk for resistant tuberculosis. Emerg Infect Dis, 2006. 12(5): p. 744-51.","DOI":"10.3201\/eid1205.050681"}],"container-title":["Journal of Clinical Tuberculosis and Other Mycobacterial Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405579420300449?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405579420300449?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T07:36:01Z","timestamp":1762500961000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405579420300449"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8]]},"references-count":29,"alternative-id":["S2405579420300449"],"URL":"https:\/\/doi.org\/10.1016\/j.jctube.2020.100180","relation":{},"ISSN":["2405-5794"],"issn-type":[{"value":"2405-5794","type":"print"}],"subject":[],"published":{"date-parts":[[2020,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tuberculosis preventive therapy (TPT) to prevent tuberculosis co-infection among adults with HIV-associated cryptococcal meningitis: A clinician\u2019s perspective","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Tuberculosis and Other Mycobacterial Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jctube.2020.100180","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"100180"}}